RTOG: Hormone Therapy Increases Survival When Combined With Radiation Therapy
Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer
Trial: Decitabine Improves Survival in Myeloid Leukemia
Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival
VEGF Levels Can Predict Tumor’s Resistance to Avastin
More Patients Get Screened, Colorectal Death Rates Drop
Revlimid Shows 91 Percent Response in Non-Hodgkin’s
Revlimid Also Demonstrates Response in Mantle Cell
FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response
Overall Cancer Mortality Rates Higher For Men Than Women
New Model For Risk Assessment Includes Alcohol, Exercise, Weight
Researchers Identify Five Genes Associated With Melanoma Risk
Stereotactic Body Radiotherapy Could Improve Overall Survival
CMS Issues Coverage Decision For Provenge in Prostate Cancer
Clinical Trials Approved By NCI CTEP Last Month
Approval Granted For New Formulation of Lupron Depot
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
